IL4Rα monoclonal antibody

IL4Rα monoclonal antibody · Genrix (Shanghai) Biopharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for IL4Rα monoclonal antibody, covering 2023-09-11 to 2025-04-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IL4Rα Monoclonal Antibody in Patients With Seasonal Allergic Rhinitis(SAR). [Phase 2]